Enanta Pharmaceuticals Inc (ENTA)

[biocqr]

Pfizer to more than double price of its COVID antiviral once drug moves to commercial market

https://www.financialjuice.com/News/7707571/-Pfizer-to-more-than-double-price-of-its-COVID-antiviral-once-drug-moves-to-commercial-market.aspx

Pfizer Inc. will charge $1,390 for a five-day course of its Paxlovid COVID-19 antiviral when the drug moves to the commercial market later this year. That’s more than double the amount the company charged the U.S. government during the pandemic.

The government paid about $529 per course when it was making Paxlovid available to patients free of cost. The news of the price increase was first reported by the Wall Street Journal.